Covered recipient · General Payments record
ERIC O GYURICSKO
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$3,639.82
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,778.64 | 3 |
| Food and Beverage | $380.35 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $1,851.70 | 6 |
| Novo Nordisk AS | $119.60 | 1 |
| Kyowa Kirin, Inc. | $40.90 | 2 |
| Azurity Pharmaceuticals, Inc. | $34.09 | 2 |
| BioMarin Pharmaceutical Inc. | $25.26 | 1 |
| BETA BIONICS, INC. | $19.93 | 1 |
| ABBVIE INC. | $19.50 | 1 |
| Insulet Corporation | $17.68 | 1 |
| Endo USA, Inc. | $16.31 | 1 |
| Amphastar Pharmaceuticals, Inc. | $14.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.50 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103857631 | CMS |
| Amphastar Pharmaceuticals, Inc. | $14.02 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149433178 | CMS |
| Azurity Pharmaceuticals, Inc. | $18.15 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134006581 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.94 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134006583 | CMS |
| BETA BIONICS, INC. | $19.93 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087878777 | CMS |
| BioMarin Pharmaceutical Inc. | $25.26 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127061236 | CMS |
| Endo USA, Inc. | $16.31 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138581413 | CMS |
| Insulet Corporation | $17.68 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116826252 | CMS |
| Kyowa Kirin, Inc. | $18.83 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127029621 | CMS |
| Kyowa Kirin, Inc. | $22.07 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127029623 | CMS |
| Novo Nordisk Inc | $119.60 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097335011 | CMS |
| PFIZER INC. | $27.15 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131919507 | CMS |
| PFIZER INC. | $20.24 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131983083 | CMS |
| PFIZER INC. | $25.67 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131050244 | CMS |
| PFIZER INC. | $539.81 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131596297 | CMS |
| PFIZER INC. | $729.83 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131596301 | CMS |
| PFIZER INC. | $509.00 | 12/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131596305 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.